Vimta Labs Limited (VIMTALABS.NS)
INR 1016.0
(2.42%)
INR 1016.0
(2.42%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 90.74 Million INR | -8.26% |
| 2022 | 98.91 Million INR | -21.89% |
| 2021 | 126.63 Million INR | -11.05% |
| 2020 | 142.36 Million INR | 164.41% |
| 2019 | 53.84 Million INR | -53.46% |
| 2018 | 115.68 Million INR | -40.56% |
| 2017 | 194.63 Million INR | 7.64% |
| 2016 | 180.81 Million INR | 12.87% |
| 2015 | 160.2 Million INR | 2770.0% |
| 2014 | -6 Million INR | 0.0% |
| 2013 | -6 Million INR | 0.0% |
| 2012 | -6 Million INR | 0.0% |
| 2011 | -6 Million INR | -102.37% |
| 2010 | 252.65 Million INR | -7.79% |
| 2009 | 273.99 Million INR | 11.28% |
| 2008 | 246.23 Million INR | -11.42% |
| 2007 | 277.96 Million INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 90.74 Million INR | 0.0% |
| 2023 Q2 | 74.36 Million INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 90.74 Million INR | -8.26% |
| 2022 FY | 98.91 Million INR | -21.89% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 123.31 Million INR | 0.0% |
| 2022 Q4 | 98.91 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2021 Q2 | 154.89 Million INR | 0.0% |
| 2021 FY | 126.63 Million INR | -11.05% |
| 2021 Q4 | 126.63 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 FY | 142.36 Million INR | 164.41% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q4 | 142.36 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q2 | 42.46 Million INR | 0.0% |
| 2019 Q2 | 77.53 Million INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 FY | 53.84 Million INR | -53.46% |
| 2019 Q4 | 53.84 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2018 Q2 | 168.48 Million INR | 0.0% |
| 2018 FY | 115.68 Million INR | -40.56% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q4 | 115.68 Million INR | 0.0% |
| 2017 Q2 | 150.53 Million INR | 0.0% |
| 2017 FY | 194.63 Million INR | 7.64% |
| 2017 Q4 | 194.63 Million INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q1 | - INR | -100.0% |
| 2016 Q4 | 180.81 Million INR | 0.0% |
| 2016 Q1 | - INR | -100.0% |
| 2016 FY | 180.81 Million INR | 12.87% |
| 2016 Q2 | 211.42 Million INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2015 Q3 | - INR | 0.0% |
| 2015 FY | 160.2 Million INR | 2770.0% |
| 2015 Q4 | 160.2 Million INR | 0.0% |
| 2015 Q2 | - INR | 0.0% |
| 2015 Q1 | - INR | 100.0% |
| 2014 Q4 | -6 Million INR | 0.0% |
| 2014 Q1 | - INR | 100.0% |
| 2014 Q3 | - INR | 0.0% |
| 2014 Q2 | - INR | 0.0% |
| 2014 FY | -6 Million INR | 0.0% |
| 2013 Q1 | - INR | 100.0% |
| 2013 FY | -6 Million INR | 0.0% |
| 2013 Q2 | - INR | 0.0% |
| 2013 Q4 | -6 Million INR | 0.0% |
| 2013 Q3 | - INR | 0.0% |
| 2012 Q4 | -6 Million INR | 0.0% |
| 2012 Q2 | - INR | 0.0% |
| 2012 FY | -6 Million INR | 0.0% |
| 2011 FY | -6 Million INR | -102.37% |
| 2011 Q4 | -6 Million INR | 0.0% |
| 2010 FY | 252.65 Million INR | -7.79% |
| 2009 FY | 273.99 Million INR | 11.28% |
| 2008 FY | 246.23 Million INR | -11.42% |
| 2007 FY | 277.96 Million INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Krsnaa Diagnostics Limited | 55 Million INR | -64.982% |
| Dr. Lal PathLabs Limited | 1.03 Billion INR | 91.19% |
| Metropolis Healthcare Limited | 1.19 Billion INR | 92.379% |
| Thyrocare Technologies Limited | 109.1 Million INR | 16.829% |
| Vijaya Diagnostic Centre Limited | 2.39 Billion INR | 96.204% |